Cargando…

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome

Haemolytic Uraemic Syndrome associated with Streptococcus pneumoniae infections (SP-HUS) is a clinically well-known entity that generally affects infants, and could have a worse prognosis than HUS associated to E. coli infections. It has been assumed that complement genetic variants associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez Delgado, Irene, Corvillo, Fernando, Nozal, Pilar, Arjona, Emilia, Madrid, Álvaro, Melgosa, Marta, Bravo, Juan, Szilágyi, Ágnes, Csuka, Dorottya, Veszeli, Nóra, Prohászka, Zoltán, Sánchez-Corral, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991904/ https://www.ncbi.nlm.nih.gov/pubmed/33777036 http://dx.doi.org/10.3389/fimmu.2021.641656

Ejemplares similares

Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
por: Gómez Delgado, Irene, et al.
Publicado: (2020)

Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012)

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013)

Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations
por: Corvillo, Fernando, et al.
Publicado: (2019)

Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
por: Venables, Julian P, et al.
Publicado: (2006)

Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017)

Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013)

Complement-activating conditions as potential triggers of pregnancy-related atypical haemolytic uraemic syndrome
por: Korotchaeva, Yulia, et al.
Publicado: (2021)

Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013)

Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome
por: Janssen van Doorn, Karin, et al.
Publicado: (2013)

A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab: A case of crosstalk between coagulation and complement?
por: Galic, Slobodan, et al.
Publicado: (2019)

The haemolytic-uraemic syndrome. A report of two cases.
por: Field, C. M., et al.
Publicado: (1965)

Haemolytic-Uraemic Syndrome as a Sequela of Diarrhoeal Disease
por: Walker, Christa L. Fischer, et al.
Publicado: (2012)

A case of lethal enteroviral haemolytic uraemic syndrome?
por: Afzal, Shoaib, et al.
Publicado: (2008)

Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
por: Walsh, Patrick R., et al.
Publicado: (2018)

Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study
por: Portoles, José, et al.
Publicado: (2020)

Complement Factor H Gene Abnormalities in Haemolytic Uraemic Syndrome: From Point Mutations to Hybrid Gene
por: Noris, Marina, et al.
Publicado: (2006)

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013)

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice
por: Delmas, Yahsou, et al.
Publicado: (2013)

Recent advances in diagnosis and treatment of atypical haemolytic uraemic syndrome
por: Bolton-Maggs, Paula HB
Publicado: (2010)

Leptospirosis presenting as haemolytic uraemic syndrome: a case report
por: Muthuppalaniappan, Vasantha Muthu, et al.
Publicado: (2018)

Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
por: Pollack, Shirley, et al.
Publicado: (2021)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
por: Kanzelmeyer, Nele Kirsten, et al.
Publicado: (2014)

Haemolytic uraemic syndrome associated with H1N1 influenza
por: Farinha, Ana, et al.
Publicado: (2010)

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome
por: Macia, Manuel, et al.
Publicado: (2017)

The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
por: Thachil, Jecko
Publicado: (2008)

Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal
por: Duineveld, Caroline, et al.
Publicado: (2020)

AZD-1222: Atypical haemolytic uraemic syndrome recurrence: case report
Publicado: (2022)

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R
por: Cserhalmi, Marcell, et al.
Publicado: (2017)

Novel complement factor H gene mutation causing atypical haemolytic uraemic syndrome: early Eculizumab prevents acute dialysis
por: Collett, James, et al.
Publicado: (2017)

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus
por: Barkai, László József, et al.
Publicado: (2019)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
por: Scully, Marie, et al.
Publicado: (2014)

Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome
por: Durán, Carlos E., et al.
Publicado: (2012)

Eculizumab in atypical haemolytic–uraemic syndrome allows cessation of plasma exchange and dialysis
por: Kim, Jon Jin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kbc715d3navjt9qqanbdbm0bub